×
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222652
Journal of the American College of Cardiology; , Bozkurt B et. al.

Jun 27th, 2022 - 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.|2022| ,Bozkurt B,Das SR,Addison D,Gupta A,|complications,epidemiology,

COVID Vaccines in Adolescents and Young Adults.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114693
The Journal of Adolescent Health : Official Publication O...

May 22nd, 2022 - Worldwide, a number of COVID-19 vaccines have been approved or granted Emergency Use Authorization (EUA) or Emergency Use Listing for adolescents and young adults (AYA), which has brought hope to many across the globe. Extension of the EUA for a COVID-19 vaccine to children and adolescents aged 5 through 15 years is exciting news for children, adolescents, parents, and providers of AYA. Many co...

Guidelines for Mobile Laboratories for Molecular Diagnostic Testing of COVID-19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057824
Annals of Laboratory Medicine; Roh KH, Hong KH et. al.

Apr 27th, 2022 - With the rapid spread of the coronavirus disease (COVID-19), the need for rapid testing and diagnosis and consequently, the demand for mobile laboratories have increased. Despite this need, there are no clear guidelines for the operation, maintenance, or quality control of mobile laboratories. We provide guidelines for the operation, management, and quality control of mobile laboratories, and s...

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Ad...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926109
Journal of the American College of Cardiology; , Gluckman TJ et. al.

Mar 22nd, 2022 - 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee.|2022| ,Gluckman TJ,Bhave NM,Allen LA,Chung EH,|complications,diagnosis,therapy,epidemiology,

Telehealth: Opportunities to Improve Access, Quality, and Cost in Pediatric Care.
https://doi.org/10.1542/peds.2021-056035
Pediatrics Curfman A, Hackell JM et. al.

Mar 1st, 2022 - The use of telehealth technology to connect with patients has expanded significantly over the past several years, particularly in response to the global coronavirus disease 2019 pandemic. This technical report describes the present state of telehealth and its current and potential applications. Telehealth has the potential to transform the way care is delivered to pediatric patients, expanding ...

ESCMID rapid guidelines for assessment and management of long COVID.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849856
Clinical Microbiology and Infection : the Official Public... Yelin D, Moschopoulos CD et. al.

Feb 20th, 2022 - The aim of these guidelines is to provide evidence-based recommendations for the assessment and management of individuals with persistent symptoms after acute COVID-19 infection and to provide a definition for this entity, termed 'long COVID'. We performed a search of the literature on studies addressing epidemiology, symptoms, assessment, and treatment of long COVID. The recommendations were g...

Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859556
Annals of Laboratory Medicine; Hong KH, Kim GJ et. al.

Feb 19th, 2022 - Korean Society for Laboratory Medicine and the Korea Disease Prevention and Control Agency have announced guidelines for diagnosing coronavirus disease (COVID-19) in clinical laboratories in Korea. With the ongoing pandemic, we propose an update of the previous guidelines based on new scientific data. This update includes recommendations for tests that were not included in the previous guidelin...

Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839802
Chest Moores LK, Tritschler T et. al.

Feb 16th, 2022 - Patients hospitalized with COVID-19 often exhibit markers of a hypercoagulable state and have an increased incidence of VTE. In response, CHEST issued rapid clinical guidance regarding prevention of VTE. Over the past 18 months the quality of the evidence has improved. We thus sought to incorporate this evidence and update our recommendations as necessary. This update focuses on the optimal app...

APLAR recommendations on the practice of telemedicine in rheumatology.
https://doi.org/10.1111/1756-185X.14286
International Journal of Rheumatic Diseases; Ahmed S, Grainger R et. al.

Jan 20th, 2022 - The COVID-19 pandemic led to rapid and widespread adoption of telemedicine in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) working group was tasked with developing evidence-based recommendations for rheumatology practice to guide maintenance of the highest possible standards of clinical care and to enable broad patient reach. A systematic review of English...

Therapeutics and COVID-19: living guideline
https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2022.1
World Health Organization (WHO)

Jan 14th, 2022 - The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges.

The Australian living guidelines for the clinical care of people with COVID-19: What wo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741039
PloS One; Turner T, Elliott J et. al.

Jan 8th, 2022 - The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline development, we undertook a concurrent process evaluation examining Taskforce activities and experience of team ...

Posters - Casirivimab and Imdevimab for COVID-19
https://www.who.int/publications/m/item/posters---casirivimab-and-imdevimab-for-covid-19
World Health Organization (WHO)

Jan 4th, 2022 - Active against alpha, beta, gamma, and delta variants of concern. Consider local epidemiological data since emerging evidence predicts decreased efficacy against Omicron.

Recommendations of the National Comprehensive Cancer Network® (NCCN®) Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis*
https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccination_guidance_v5-0.pdf?sfvrsn=b483da2b_74
National Comprehensive Cancer Network® (NCCN®)

Jan 4th, 2022 - The committee endorses vaccination for all eligible persons based on FDA-approved indications or emergency use authorization (EUA). With the widespread availability of highly effective and safe vaccines, the committee reiterates the need for patients with cancer to be fully immunized, including receiving third doses and boosters.

Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a st...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015333
Journal of Surgical Oncology; Brajcich BC, Benson AB et. al.

Nov 26th, 2021 - COVID-19 has resulted in significant disruptions in cancer care. The Illinois Cancer Collaborative (ILCC), a statewide multidisciplinary cancer collaborative, has developed expert recommendations for triage and management of colorectal cancer when disruptions occur in usual care. Such recommendations would be applicable to future outbreaks of COVID-19 or other large-scale disruptions in cancer ...

Living guidance for clinical management of COVID-19
https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2
World Health Organization (WHO)

Nov 23rd, 2021 - The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.

2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on St...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763451
Thrombosis and Haemostasis; Chao TF, Joung B et. al.

Nov 14th, 2021 - The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in the Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The practice guidelines sub...

Virtual integrated primary care teams: Recommendations for team-based care.
https://doi.org/10.1037/fsh0000655
Families, Systems & Health : the Journal of Collaborative... Mitzel LD, Funderburk JS et. al.

Nov 5th, 2021 - Integrated primary care teams are increasingly relying upon virtual care, including both telehealth and team members who are teleworking, due to the COVID-19 pandemic. This shift to virtual care can present challenges for the coordination and provision of team-based care in primary care. The current report uses extant literature on teams to provide recommendations to support integrated primary ...

American Society of Hematology living guidelines on the use of anticoagulation for thro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566097
Blood Advances; Cuker A, Tseng EK et. al.

Nov 3rd, 2021 - COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in decisions about the use of anticoagulation for thromboprophylaxis in patients with COVID-19 who do not have confirmed or suspected VTE....

Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Presentation
https://www.fda.gov/media/153037/download
US Food and Drug Administration (FDA)

Oct 15th, 2021 - On February 27, 2021, FDA issued an Emergency Use Authorization for the Janssen COVID-19 Vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. The Janssen COVID-19 vaccine, also referred to as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S prot...

2021 update of the EULAR points to consider on the use of immunomodulatory therapies in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507408
Annals of the Rheumatic Diseases; Alunno A, Najm A et. al.

Oct 9th, 2021 - To update the EULAR points to consider (PtCs) on the use of immunomodulatory therapies in COVID-19. According to the EULAR standardised operating procedures, a systematic literature review up to 14 July 2021 was conducted and followed by a consensus meeting of an international multidisciplinary task force. The new statements were consolidated by formal voting. We updated 2 overarching principle...